| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24232 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9fc83255b6fe6b0e21ae40a7df67c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc842a8eb1fc3f07823f025f4c6b2003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ead4eec8f6f46ff67abdc7e384845e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfc17ccd0b7d7eaa45ff4aaf6abdb08d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620a70808d339712e04afc716378f22e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2947df8dfabbe625925a07fd7a7422 |
| publicationDate |
2019-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201919675-A |
| titleOfInvention |
Combination therapy for individuals infected with hepatitis B virus (HBV) using Parapoxvirus ovis (PPVO) and at least one additional antiviral drug |
| abstract |
The present invention is a novel combination therapy for HBV-infected individuals using parapoxvirus ovis (PPVO) and at least one additional antiviral agent, such as a nucleoside inhibitor, such as Entecavir. The methods and combination products according to the present invention are safe and suitable for inducing a functional cure in patients with chronic HBV infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I796688-B |
| priorityDate |
2017-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |